Navigation Links
Scientists to design drug for chronic pain
Date:8/24/2012

Scientists at the University of Liverpool and the Royal Liverpool University Hospital have been awarded 1.4 million to design a new drug for the treatment of chronic pain.

The project funded by the Medical Research Council (MRC), addresses the long-standing and urgent need for effective therapies for chronic pain which affects around 20% of adults in Europe and the US, and more than eight million adult patients in the UK alone. Medication currently available to treat the condition is effective in only around 40% of sufferers and even these patients often struggle to maintain the balance between adequate pain relief and the adverse effects of current therapies.

The research team is examining compounds which target the glycine receptor, one of the principal inhibitory neuronal receptors in the central nervous system and crucial in the sensation of chronic pain. Through medicinal chemistry, computational methods and experimental testing, scientists successfully identified novel compounds which could be used for the treatment of chronic pain without unwanted sedative effects.

Professor Martin Leuwer, from the University's Department of Molecular and Clinical Pharmacology in the School of Translational Medicine, said: "This is an exciting project that expands our drug discovery portfolio into a new therapeutic area with a huge unmet medical need. Our collaborative team of medicinal chemists, molecular modellers and neurobiologists have made significant advances in this area and this funding provides us with the opportunity to drive the project forward towards an entirely new class of drug for the treatment of chronic pain conditions.

"We're aiming to develop molecules that target the glycine receptor, into a drug that can be administered as a tablet. Our project concept has been shown to work but further improvements are required if we are to reach the goal of generating a drug which is safe, effective and orally viable. Our ul
'/>"/>

Contact: Kate Mizen
kate.mizen@liv.ac.uk
0044-151-794-2247
University of Liverpool
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists from UCLA, Israels Technion uncover brains code for pronouncing vowels
2. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
3. UCSB scientists examine effects of manufactured nanoparticles on soybean crops
4. Scientists report promising new direction for cognitive rehabilitation in the elderly
5. Scientists to investigate preventing life-threatening complications in transplant patients
6. Scientists decode TREX which could see new treatments for cancer realized
7. Scientists devise new strategy to destroy multiple myeloma
8. Scientists ID New Gene Regions Linked to Type 2 Diabetes
9. Scientists discover how iron levels and a faulty gene cause bowel cancer
10. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
11. Scientists ID New Gene Linked to Vision Loss in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... How best to treat and recover from ... medicine. While diagnostic hip injections are commonly performed for ... research presented today at the American Orthopaedic Society for ... pain relief from this diagnostic injection may not predict ... study looked to assess if the amount of pain ...
(Date:3/28/2015)... OR (PRWEB) March 28, 2015 Lately ... the media regarding recent changes and proposals around the ... , current and former collegiate student-athletes across a spectrum ... and reflect on common challenges. The special panel consists ... country in sports ranging from football, track and field, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 ARDX will sponsor ... from 12pm -3pm at the Chesapeake Conference Center in Chesapeake, ... sponsoring an empowering event for women in the Hampton Roads ... the Stories of Women’s Lives. Women grow stronger through ... each other. This year the WWC™ theme is T-talk ...
(Date:3/27/2015)... Long Island, NY (PRWEB) March 27, 2015 ... objective, cancer-focused training and business criteria for the spa ... and services to clients who have experienced or are ... of the global Spafinder Wellness 365® Network, will be ... Spafinder.com and recognized as a provider of safe, therapeutic ...
(Date:3/27/2015)... Mo (PRWEB) March 27, 2015 ... for patients undergoing percutaneous coronary intervention (PCI), resulting ... have observed a “risk-treatment paradox,” in which the ... from treatment are treated less often with bleeding ... at Saint Luke’s Mid America Heart Institute asked ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3
... ... don,t need the pretty bottles or sweet aroma of fragrant lotions and cleansers-men ... tailored specifically to a man,s needs without added synthetic ingredients that may be ... uses the purity of nature to enhance the skin,s surface and makes a ...
... ... Drive in Beverly Hills to Main Street in small towns across America. The medical community ... growing epidemic. , ... PA (PRWEB) June 1, 2010 -- Nearly 7 million Americans are abusing prescription drugs – ...
... ... Harmful Bacteria, Including MRSA. Jan-Pro, Global Leader in Commercial Cleaning, Once Again Leads the ... Offer Powerful New Solution in the control of infectious microorganisms - EnviroShield Disinfectant Technology ... (PRWEB) June ...
... ... of a novel combination of two FDA Approved topical medications. This triple blind controlled ... ... Oscar Klein M.D. today announced the results of a triple blind hair loss research study ...
... ... a brand new buy back plan. , ... (PRWEB) – CosmeticLaserWorld.com ( www.cosmeticlaserworld.com ), a market leader in ... should purchase equipment from the reseller. Under an Investment Protection Plan, the company will ...
... - Shionogi Pharma, Inc., a U.S.-based group company of ... results of two pivotal studies of the investigational new ... for the treatment of primary premature ejaculation (PE). These ... (AUA) Annual Meeting in San Francisco. Evaluating a ...
Cached Medicine News:Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 2Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 3Health News:Garden of Eve Launches a Father's Day Tribute for Men Who Want to Look Well-groomed with Little Fuss 4Health News:Medical Community Responds to Prescription Drug Abuse 2Health News:Medical Community Responds to Prescription Drug Abuse 3Health News:JAN-PRO Launches Exclusive “EnviroShield™” Disinfecting System - Kills Harmful Bacteria, Including MRSA 2Health News:JAN-PRO Launches Exclusive “EnviroShield™” Disinfecting System - Kills Harmful Bacteria, Including MRSA 3Health News:Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness 2Health News:Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness 3Health News:CosmeticLaserWorld.com Gives Buyers Peace of Mind Through Industry-Leading Investment Protection Plan 2Health News:Pivotal data for the investigational treatment PSD502 for primary premature ejaculation 2Health News:Pivotal data for the investigational treatment PSD502 for primary premature ejaculation 3
(Date:3/27/2015)... -- Victoria Vein & Surgery Clinic is the only clinic offering ... Victoria, Texas . The clinic specializes in ... treatments for a variety of medical and cosmetic conditions. High-end ... services for their patients. Since adding laser tattoo removal, Victoria ... residents get rid of their unwanted ink. ...
(Date:3/27/2015)... YORK , March 27, 2015 A new ... Latin America – Chile ... are top targets for IVD firms.  The healthcare ... figures heavily into IVD strategies for the Latin American continent ... to support globally distributed supply operations. However, the country,s regional ...
(Date:3/27/2015)... CAMBRIDGE, Mass. , March 27, 2015 /PRNewswire/ ... unique platform for drug discovery and development services ... assays for the pharmaceutical industry, announced financial results ... Timothy C.  Tyson, Chairman of XRpro ... steps to successfully transition from development stage to ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to... -- DALLAS, September 6, 2010 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... The editors of Inc. Magazine have included Qosina Corporation, ... 5000" List , which acknowledges the top 5,000 fastest ... being recognized for the second consecutive year on the ... the "Inc. 500" in 1989 and "Inc. 5000" in ...
Cached Medicine Technology:Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 2Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 3Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 4Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 5Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 6Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 7Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports 8Qosina Recognized for Second Consecutive Year on the 'Inc. 5000' List 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: